Charles River

Read more
James C. Foster's photo - Chairman & CEO of Charles River

Chairman & CEO

James C. Foster

CEO Approval Rating

71/100

Founded:

1947

Status:

PublicIndependent CompanyNYSECRL

CHARLES RIVER TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

IQVIA is Charles River's top competitor. IQVIA is headquartered in Durham, North Carolina, and was founded in 1954. Like Charles River, IQVIA also operates in the Biotechnology field. IQVIA generates 395% the revenue of Charles River.

PPD is seen as one of Charles River's top competitors. PPD's headquarters is in Wilmington, North Carolina, and was founded in 1985. Like Charles River, PPD also works within the Biotechnology industry. PPD generates 163% of Charles River's revenue.

LabCorp has been one of Charles River's top competitors. LabCorp was founded in 1905, and its headquarters is in Burlington, North Carolina. Like Charles River, LabCorp also works within the Biotechnology field. LabCorp has 57,700 more employees than Charles River.

Charles River Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$3B

Charles River's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 4.5B. Over the last four quarters, Charles River's revenue has grown by 20.8%. Specifically, in Q1 2021's revenue was $824.6M; in Q4 2020, it was $791M; in Q3 2020, it was $743.3M; in Q2 2020, Charles River's revenue was $682.6M.

Charles River Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Vigene Biosciences, Inc.

May 2021

Source »
$292.5M
Vigene is a Maryland-based biotechnology company that develops and commercializes viral vector-based gene therapy products for research and clinical applications.
Retrogenix Limited

Mar 2021

Source »
$48M
Retrogenix is an England-based contract research organization that provides cancer immunology research and consulting services for the pharmaceutical industry.
Cognate BioServices, Inc.

Feb 2021

Source »
$875M
Cognate is a contract manufacturing organization that provides gene therapy-based clinical development services for the pharmaceutical sector.
Distributed Bio, Inc.

Dec 2020

Source »
$83M
Distributed Bio develops a San Francisco-based cloud computational platform that provides antibody repertoire analysis and therapeutic discovery solutions.
Cellero

Aug 2020

Source »
$38M
Cellero is a life science company that provides biomaterials and characterized immune cells for cell therapy developers.

These are all the companies that Charles River has acquired. Charles River has acquired 21 companies and its latest acquisition was Vigene Biosciences, Inc. in May 2021. Vigene is a Maryland-based biotechnology company that develops and commercializes viral vector-based gene therapy products for research and clinical applications.

Charles River Funding History

Since Charles River was founded in 1947, it has participated in 3 rounds of funding. In total Charles River has raised $1.7B. Charles River's last funding round was on Mar 2021 for a total of $1.0B

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Mar 2021
$1B
-
Debt
Apr 2018
$500M
-
IPO
Jun 2000
$224M
-

Since Charles River was founded in 1947, it has participated in 3 rounds of funding. In total Charles River has raised $1.7B. Charles River's last funding round was on Mar 2021 for a total of $1.0B

Charles River Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

JADE is a contract quality organization that provides regulatory and analytical testing services for biopharmaceutical companies.
-
Feb 17, 2021
Equity
-
PathoQuest provides clinical diagnostics and biologic testing applications for biopharmaceutical companies.
$8.8M
Sep 04, 2019
Debt
-
Resero Analytics develops an online software that provides data management solutions for the pharmaceutical industry.
-
May 15, 2019
Equity
-
Standard develops an AI-based computer vision platform that offers autonomous checkout solutions for brick and mortar retailers.
$5M
Oct 09, 2017
Seed
-

These are all the companies that Charles River has invested in. Charles River has invested 4 companies and its latest investment was JADE in Feb 17,. JADE is a contract quality organization that provides regulatory and analytical testing services for biopharmaceutical companies.

Charles River News

Charles River Blogs

Charles River Press Releases

Charles River Videos

Social Media

Charles River Headquarters

251 Ballardvale Street

Wilmington, Massachusetts01887

1-781-222-6000

Driving Directions »

Trending Companies

Charles River Summary

ABOUT

Overview

Charles River is a Massachusetts-based corporation specializing in preclinical and clinical lab services for the pharmaceutical, medical device and biotechnology industries. Charles River was founded in 1947. Charles River's headquarters is located in...

CEO

Charles River's Chairman & CEO, James C. Foster, currently has an approval rating of 71%. Charles River's primary competitors are IQVIA, PPD & LabCorp.

Website

criver.com

Frequently Asked Questions about Charles River

  1. When was Charles River founded?

    Charles River was founded in 1947
  2. Who is Charles River's CEO?

    Charles River's CEO is James C. Foster
  3. How much revenue does Charles River generate?

    Charles River generates $3B in revenue
  4. How much funding does Charles River have?

    Charles River has historically raised $1.7B in funding
  5. Where is Charles River's headquarters?

    Charles River's headquarters is in Wilmington Massachusetts, USA
  1. How many employees does Charles River have?

    Charles River has 14,700 employees
  2. What sector does Charles River operate in?

    Charles River is in Biotechnology, Pharmaceuticals
  3. Who are Charles River's competitors?

    Charles River's top competitors are IQVIA, PPD, LabCorp
  4. Who has Charles River invested in?

    Charles River's has invested in companies such as JADE, PathoQuest, Resero Analytics